Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada.
Global Cancer Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
BMJ Open. 2023 Feb 6;13(2):e068122. doi: 10.1136/bmjopen-2022-068122.
Antimicrobial resistance (AMR) is a growing global public health concern and is becoming a significant challenge in the management of patients with cancer. Due to the immunosuppressive nature of cancer treatment, infection is a common complication and the necessary high usage of antibiotics increases the risk of AMR. Failure to adequately prevent and treat infection in patients with cancer as a result of AMR can increase the morbidity and mortality of the disease. The objective of this scoping review is to understand the relationship between AMR and cancer in order to develop effective antimicrobial stewardship in this patient population and minimise the detrimental effects of AMR on cancer outcomes.
This scoping review will follow the Arksey and O'Malley methodology framework. An exploratory review of the literature on antibiotic resistance in cancer care will help to define the research questions (stage 1). A broad range of electronic databases (MEDLINE ALL, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews and Embase) and search terms will be used to retrieve relevant articles published between 2000 and 2021 (stage 2). Studies will be systematically selected based on the eligibility criteria by two independent reviewers (stage 3). The titles and abstracts will be appraised to determine whether articles meet the eligibility criteria. This will be followed by screening of the full texts and only relevant publications will be retrieved. Data will then be extracted, collated and charted (stage 4); and the summary of aggregated results will be presented (stage 5).
As this scoping review will collect and synthesise data from publicly available sources, no ethics review is required. When data collection and summarisation is completed, results will be disseminated through peer-reviewed publication and the key findings of the review will be presented at relevant conferences.
抗菌药物耐药性(AMR)是一个日益严重的全球公共卫生问题,并且在癌症患者的管理中成为一个重大挑战。由于癌症治疗具有免疫抑制特性,感染是常见的并发症,而抗生素的大量使用增加了 AMR 的风险。由于 AMR,未能充分预防和治疗癌症患者的感染会增加疾病的发病率和死亡率。本范围综述的目的是了解 AMR 与癌症之间的关系,以便在这一患者群体中制定有效的抗菌药物管理策略,并最大限度地减少 AMR 对癌症结局的不利影响。
本范围综述将遵循阿斯基和奥马利的方法框架。对癌症护理中抗生素耐药性的文献进行探索性综述,有助于确定研究问题(第 1 阶段)。将使用广泛的电子数据库(MEDLINE ALL、Cochrane 对照试验中心注册、Cochrane 系统评价数据库和 Embase)和搜索词检索 2000 年至 2021 年期间发表的相关文章(第 2 阶段)。将根据纳入标准由两名独立评审员系统地选择研究(第 3 阶段)。将评估标题和摘要以确定文章是否符合纳入标准。随后,将筛选全文,仅检索相关出版物。然后将提取、整理和图表化数据(第 4 阶段);并呈现汇总结果的摘要(第 5 阶段)。
由于本范围综述将从公开来源收集和综合数据,因此不需要进行伦理审查。当数据收集和总结完成后,将通过同行评审出版物进行结果传播,并将在相关会议上介绍综述的主要发现。